Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2006248780 (hide)

Owner AstraZeneca AB

Inventors Wang, Bin; Wang, Tao

Agent Davies Collison Cave

Pub. Number AU-B-2006248780

PCT Pub. Number WO2006/123113

Priority 60/681,515 16.05.05 US; 60/722,282 30.09.05 US

Filing date 12 May 2006

Wipo publication date 23 November 2006

Acceptance publication date 3 June 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/123113 Priority application(s): WO2006/123113

3 June 2010 Application Accepted

  Published as AU-B-2006248780

30 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006248786-Imaging device and method

2006248771-Methods to increase recovery of treatment fluid following stimulation of a subterranean formation